Design Therapeutics, Inc. DSGN Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s quick ratio?
- Design Therapeutics, Inc. (DSGN) reported quick ratio of 22.3× in Q1 2026.
- How has Design Therapeutics, Inc.'s quick ratio changed year-over-year?
- Design Therapeutics, Inc.'s quick ratio decreased by 21.5% year-over-year, from 28.4× to 22.3×.
- What is the long-term trend for Design Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s quick ratio has grown at a 2.0% compound annual growth rate (CAGR), from 15.6× to 17.1×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.